Global Artificial Tear Market Reaches $2,565.4 Million in 2025 with 5.3% CAGR

Artificial tear market was valued at $2,565.4 million in 2025 and is projected to reach $4,275.0 million by 2035, growing at a CAGR of 5.3% during the forecast period (2026-2035). The market expansion is driven by the rising prevalence of dry eye syndrome, increasing screen time and digital device usage, aging populations, and growing awareness of ocular health. Artificial tear products, including lubricating eye drops, gels, ointments, and preservative-free formulations, are increasingly preferred for managing dry eye symptoms and improving patient quality of life. Key trends shaping the market include the development of preservative-free and multi-dose formulations, integration of advanced hydrating polymers and natural extracts, and increasing adoption of over-the-counter (OTC) products for self-managed eye care. Regional growth is supported by rising healthcare access, greater ophthalmology awareness, and targeted marketing initiatives by key manufacturers.

Browse the full report description of “Artificial Tear Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Delivery Method (Eyedrops and Ointments/Gel), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) and By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/artificial-tears-market

According to PMC and the National Eye Institute (NEI), the use of artificial tears and other tear supplements is increasing steadily as dry eye disease (DED) continues to affect a large portion of the population, prompting hospitals, clinics, and individuals to rely more on these products to manage symptoms and improve quality of life.

Key Innovators Driving Artificial Tear Transformation

The key players in the artificial tear market include AbbVie, Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson, Santen Pharmaceutical Co., Ltd among others. These companies are driving innovation through new formulations, enhanced delivery systems, and global distribution strategies.

• In May 2025, Alcon launched Systane Ultra PF+, an upgraded preservative-free formulation featuring advanced moisture-locking polymers to enhance tear-film stability, particularly for patients with severe evaporative dry eye. The product also incorporates a redesigned multi-dose preservative-free bottle for improved ease of use and dosing accuracy.
• In March 2025, Johnson & Johnson Vision introduced Blink Complete Advanced Lipid Tears, a next-generation nano-emulsion artificial tear designed to restore the lipid layer and reduce tear-film evaporation in chronic dry eye patients. The formulation strengthens the company’s premium dry-eye portfolio, offering extended-duration relief.
• In January 2025, Bausch + Lomb announced the global expansion of its Biotrue Hydration Boost PF line, featuring hyaluronic acid–enriched, preservative-free drops inspired by the eye’s natural biology. The rollout includes wider retail and online distribution to meet increasing global demand for gentle, long-term dry eye solutions.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • Delivery Method
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - AbbVie, Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson, Santen Pharmaceutical Co., Ltd among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Artificial Tear Market Report Segment

By Type

• Cellulose-Derived Tears
• Glycerin-Derived Tears
• Oil-Based Emulsion Tears
• Polyethylene Glycol- & Propylene Glycol-Based Tears

By Delivery Method

• Eyedrops
• Ointments/Gel

By Application

• Dry Type Treatment
• Contact Lens Moisture
• Digital Eye Strain

By End-User

• Retail Pharmacies (OTC)
• Online Pharmacies
• Hospitals & Ophthalmic Clinics
• Other End User

Artificial Tear Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/artificial-tears-market